Gilteritinib, sold under the brand name Xospata, is an anti-cancer drug. It acts as an inhibitor of FLT3, hence it is a tyrosine kinase inhibitor.Gilteritinib has been repurposed as a potential antiviral drug as a possible application in the treatment of COVID-19. Reference standards of Gilteritinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Gilteritinib
Catalogue No.:PA 07 0840000
CAS :
Molecular Formula : C29H44N8O3
Molecular Weight : 552.72
Gilteritinib-D5
Catalogue No.:PA STI 089081
Molecular Formula : C29H39D5N8O3
Molecular Weight : 557.75
6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carbonitrile
Catalogue No.:PA 07 0841000
Molecular Formula : C29H42N8O2
Molecular Weight : 534.71
6-Ethyl-3-((3-methoxy-4-(4-(piperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide
Catalogue No.:PA 07 0841001
Molecular Formula : C28H42N8O3
Molecular Weight : 538.7
3-Methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)aniline
Catalogue No.:PA 07 0841002
Molecular Formula : C17H28N4O
Molecular Weight : 304.44
Gilteritinib N-Methyl N-Oxide Impurity
Catalogue No.:PA 07 0841003
Molecular Formula : C29H44N8O4
Molecular Weight : 568.72
Gilteritinib N-Oxide Impurity
Catalogue No.:PA 07 0841004
3-((4-(4-(4-(5-Carbamoyl-3-ethyl-6-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrazin-2-yl)piperazin-1-yl)piperidin-1-yl)-3-methoxyphenyl)amino)-6-ethyl-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide
Catalogue No.:PA 07 0841005
Molecular Formula : C52H75N15O5
Molecular Weight : 990.27
Gilteritinib Carboxylic Acid
Catalogue No.:PA 07 0841006
Molecular Formula : C29H43N7O4
Molecular Weight : 553.71
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
